Trial Profile
Efficacy and Safety of RAD001 (Everolimus) in Patients Affected by Biliary Tract Cancer Progressing After Prior Chemotherapy: a Phase II I.T.M.O. Study.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Sep 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Biliary cancer
- Focus Biomarker; Therapeutic Use
- 02 Jul 2011 New trial record